The American Cancer Society predicts 1 in 8 men will be diagnosed with prostate cancer in their lifetime.

Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine whether prostate tumors remain sensitive to treatment or evolve into a more ...

A new study by the Medical University of Vienna found that a specialized form of imaging could identify 91% of prostate cancer cases without the need for a biopsy. Traditionally, a blood test can ...

A systematic review of eight studies finds that higher prostate MRI quality shows inconsistent and very-low-certainty associations with the confirmation of clinically significant prostate cancer among ...

Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine ...

A new study revealed molecular features linked to more aggressive prostate cancer in a subset of patients who had been ...

PACE is the first phase 3 randomized trial directly comparing radical prostatectomy with SBRT in men with low- to intermediate-risk prostate cancer.

A tracer originally designed to hunt prostate cancer is proving to be an unexpected ally in one of the world’s deadliest ...

Fagundes, MD, discussed when proton therapy is most justified over photon approaches in prostate cancer. In an interview with ...

About 1 in 8 men will learn that they have prostate cancer at some point in their lifetime. And while most who are diagnosed will survive, prostate cancer can be serious. It’s the second-leading cause ...

A new theranostics suite is streamlining treatment and clinical trials for certain types of cancer, notably prostate cancer ...

Most men may be missing an important dietary clue about prostate cancer. A new survey found that only 20% knew research has linked dairy consumption with increased prostate cancer risk, while 66% said ...